Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Opens Spectroscopy-focused Center in Singapore

NEW YORK (GenomeWeb News) – PerkinElmer today opened a new facility in Singapore that will focus on developing tools for drug discovery, environmental monitoring, food safety testing, and sustainable energy, the company said today.
 
The PerkinElmer Center of Excellence in Singapore will make instruments for atomic absorption spectroscopy and UV/visible spectroscopy that can be used to detect organic and inorganic materials in the environment, food, materials, and oil industries.
 
The center also will also support R&D activities for the company’s EcoAnalytix solution line, which is an initiative focused on food and consumer product safety, water quality, and sustainable energy development programs.
 
The Waltham, Mass.-based company is currently “making significant and long-term investments in Asia-Pacific to support the expansion of the health and environmental infrastructures of emerging growth nations,” VP and CSO Daniel Marshak said in a statement.
 
The company said that it views Asia-Pacific as a “key growth region” for pharmaceutical research, neonatal and prenatal screening, and environmental monitoring.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.